| Scientific Name | Canagliflozin |
|---|---|
| Brand Name | Invokana |
| Risk | Risk of diabetic ketoacidosis, Risk of Fournier´s gangrene (necrotising fasciitis of the perineum) with Sodium-Glucose-Co-Transporter 2 inhibitor, Risk of Rare but Serious Infection in the Genital Area with Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Advice on the Risk of Lower Limb Amputation Primarily of the Toe during treatment with canagliflozin. |
| Safety Communication for Healthcare Professionals |
